Bio-Rad Labs (BIO) to Acquire Stilla Technologies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Bio-Rad Labs (BIO) PT Lowered to $400 at Citi
February 14, 2025 9:19 AM ESTCiti analyst Patrick Donnelly lowered the price target on Bio-Rad Labs (NYSE: BIO) to $400.00 (from $450.00) while maintaining a Buy rating.
The analyst comments "BIO guided core FY25 to grow +1.5-3.5% vs. consensus of +2.5%, with Life Sci at +1.5-3.5% vs. Dx at +2-3%. GM /... More



